(Q69061937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

The enhanced monocyte and neutrophil chemotaxis in psoriasis is normalized after treatment with psoralens plus ultraviolet A and anthralin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

T Ternowitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

language of work or name

English

0 references

publication date

1 June 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Academy of Dermatology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

1169-1175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?

29 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Increased chemotactic activity of neutrophil leukocytes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Neutrophil and monocyte chemotaxis in pustulosis palmo-plantaris and pustular psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Neutrophil chemotaxis in psoriasis before and after PUVA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Neutrophil leukocyte migration in psoriasis vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Effect of anthralin on stratum corneum antigenicity and polymorphonuclear leukocyte chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Cutaneous blood flow in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Leukocyte chemotaxis after in vitro treatment with 8-methoxypsoralen and UVA

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Effects of in vitro PUVA on human leukocyte function.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Chemotactic lipoxygenase products in sera from patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Effect of 8-Methoxypsoralen Plus UVA on Psoriasis Leukotactic Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2887%2970152-2

7 January 2021

10.1016/S0190-9622(87)70152-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3597858%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference